Latest Breaking News On - Biologics license application - Page 28 : comparemela.com

FDA Declines To Approve Expanded Use of Dynavax s Hepatitis B Vaccine In Hemodialysis Patients - Dynavax Technologies (NASDAQ:DVAX)

FDA Declines To Approve Expanded Use of Dynavax s Hepatitis B Vaccine In Hemodialysis Patients - Dynavax Technologies (NASDAQ:DVAX)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainRob janssenEuropean commissionEuropean unionDynavax technologiesBiologics license applicationComplete response letterChief medical

FDA Issues CRL for HEPLISAV-B in Adults on Hemodialysis

FDA Issues CRL for HEPLISAV-B in Adults on Hemodialysis
hcplive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hcplive.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainRob janssenLinkedin rob janssenDrug administrationDrug administration for biologics license applicationEuropean unionComplete response letterBiologic license applicationEuropean commissionChief medical officerToll like receptorDynavax provides regulatory updateDynavax announcesDynavax receivesResponse letter

Zenocutuzumab Gets Priority Review for NRG1+ NSCLC and Pancreatic Cancer

Zenocutuzumab Gets Priority Review for NRG1+ NSCLC and Pancreatic Cancer
oncologynurseadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oncologynurseadvisor.com Daily Mail and Mail on Sunday newspapers.

Andrew joeDrug administrationPriority reviewBiologics license applicationChief medical officer

Dynavax Receives FDA s CRL Regarding Four-Dose Heplisav-B Vaccine For Hemodialysis Patients

Dynavax Receives FDA s CRL Regarding Four-Dose Heplisav-B Vaccine For Hemodialysis Patients
rttnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rttnews.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainDrug administrationDynavax technologies corpEuropean unionDynavax technologiesComplete response letterBiologics license application

Longeveron Announces First Quarter 2024 Financial Results

Longeveron Announces First Quarter 2024 Financial Results
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesDerek coleNational heartDrug administrationAlzheimer association international conferenceResearch oral presentationNational institutes of healthDevelopment expensesInvestor relations advisory solutionsDevelopment programsTrademark officeBlood instituteExchange commission onExchange commissionLongeveron incFeatured research oral presentation